Malin shares rise as it buys stake in UK drugs firm

Shares in Irish life sciences and biotech investment firm, Malin Corporation, rose 4% as it bought a 33% stake in UK company, Wren Therapeutics, which is focused on drugs used to fight Alzheimer’s and Parkinson’s Disease.

Malin shares are listed on the Irish Stock Exchange’s Enterprise Securities Market (ESM).

Cambridge-based Wren focuses on drug discovery and clinical translation of molecules that will impact 30 protein misfolding diseases, such as Alzheimer’s and type-2 diabetes.